Page Tools:

100 Questions & Answers About Liver Cancer, Third Edition

Author(s): Ghassan K. Abou-Alfa, MD, MBA, Gastrointestinal Service, Memorial Sloan-Kettering Cancer Center, Weill-Medical College, Cornell University, New York, New York
Ronald DeMatteo, MD, Perelman School of Medicine at the University of Pennsylvania, Pennsylvania
Details:
  • ISBN-13: 9781449622893
  • Paperback    138 pages      © 2013
Price: $20.95 US List
Add to Cart

Whether you're a newly diagnosed patient, survivor, or loved one of someone suffering from liver cancer, 100 Questions & Answers About Liver Cancer, Third Edition offers essential and practical guidance. Providing both doctor and patient perspectives, this completely updated and revised edition offers authoritative answers to the most commonly asked questions about liver cancer including diagnosis, treatment, post-treatment quality of life, and coping strategies. Written by a medical oncologist and a gastrointestinal surgeon, with actual patient commentary, 100 Questions & Answers About Liver Cancer, Third Edition is an invaluable resource for anyone coping with the physical and emotional turmoil of this disease.

Part  1  The Basics
Part  2  Risk Factors
Part  3  Screening
Part  4  Diagnosis and Staging
Part  5  Coping with the Diagnosis
Part  6  Treatment
Part  7  Cancer-Related Practical Issues
Part  8  Cirrhosis-Related Practical Issues
Part  9  Social and End-of-Life Issues

Ghassan K. Abou-Alfa, MD, MBA-Gastrointestinal Service, Memorial Sloan-Kettering Cancer Center, Weill-Medical College, Cornell University, New York, New York

Ghassan K. Abou-Alfa, MD, is a member of the Gastrointestinal Oncology Service at Memorial Sloan-Kettering Cancer Center in New York, where he specializes in the treatment of primary liver cancer. He received his medical degree from the American University of Beirut, Lebanon, and completed his post-doctoral training at Yale University School of Medicine, before joining the faculty of Memorial Sloan-Kettering. His research is dedicated to improving the effectiveness of cancer therapy by incorporating small biological molecules that target cancer therapy into the treatment regimen for chemotherapy-resistant liver cancer. Dr. Abou-Alfa is a strong advocate for raising awareness about liver cancer and has lectured on the subject at universities worldwide.

Additional Titles by this Author

Ronald DeMatteo, MD-Perelman School of Medicine at the University of Pennsylvania, Pennsylvania

Ronald DeMatteo, MD, is a member of the Hepatobiliary Service in the Department of Surgery at Memorial Sloan-Kettering Cancer Center. He specializes in the treatment of liver, bile duct, and pancreas tumors. Dr. DeMatteo received his medical degree from Cornell Medical College and completed a surgical residency at the University of Pennsylvania. He was a fellow in Surgical Oncology at Memorial Sloan-Kettering Cancer Center before joining the staff. Dr. DeMatteo also performs laboratory research where he investigates how the immune system can be used to fight cancer. 

Additional Titles by this Author